Grey Matters Secures Final Regulatory License for Florida Neuroimaging Clinic
AGNPF sits 49% above its 52-week low of $0.218 on light trading volume (0.1× avg).
Summary
Grey Matters received its Radioactive Materials License from Florida, the last major regulatory step for its flagship NovaScan Neuroimaging Clinic in Davie, set to open by September 30th. This clears the path for the company's first U.S. clinic to begin operations, moving from pre-revenue planning to actual service delivery. The license is a concrete, non-routine milestone that de-risks the near-term launch. With a market cap under $3 million, successful clinic opening could materially change the company's revenue profile. Watch for the clinic's actual opening and first patient scans.
At the time of this announcement, AGNPF was trading at $0.33 on OTC in the Life Sciences sector, with a market capitalization of approximately $2.9M. The 52-week trading range was $0.22 to $9.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.